Is Your Protein Aging You? What the Longevity Science Gets Wrong

0:00Dr. Gabrielle Lyon:Here's the paradox I want to address with you today. The molecular pathway that the longevity world wants you to suppress is the same pathway that builds and protects muscle. We know that muscle is the single and strongest, most modifiable predictor of whether you stay independent or frail. The protein scare is a case study in how biology can outrun real evidence. Protein does raise IGF-1, but here's the lever everyone's pulling on the wrong end. In a body with insulin resistance, chronic high insulin from too much refined carbohydrates means bioavailable IGF-1 runs high all the time. Not because of protein, because of the insulin.

0:45The biggest driver of your IGF-1 is your growth hormone set by your genes, your age, your sleep, and your body composition. The longevity message asks the people most likely to die of muscle loss to eat less of the only thing that defends them. So what is actually killing people at scale isn't a slightly busy growth pathway.

1:08Dr. Gabrielle Lyon:It's frailty. It's the slow, silent, entirely preventable loss of the muscle you were told to stop feeding. So here's the plan.

1:24Dr. Gabrielle Lyon:The longevity world has convinced a generation of women that protein is shortening their lives. The science says they've got it backwards. And the people most hurt by the message are the ones in perimenopause who need protein the most. Now, here's a quick disclaimer. I am not your physician, and this episode is for educational purposes only, not medical advice. And if you have kidney disease or any other illness, please talk to your healthcare provider. I have to address something head on because I keep hearing it from you. It's all over the comments and frankly, it's creating real torment. The fear is this, dietary protein will shorten your life.

2:04Dr. Gabrielle Lyon:That every chicken breast, every egg, steak is aging you, feeding cancer, switching on the machinery of your own decline. This idea didn't come out of nowhere. It was actually popularized by scientists in the longevity world. Guys like Walter Longo, whose lab has produced some of the most cited work on this. David Sinclair and the broader anti-aging movement. And it lands hardest on one specific person. The woman in perimenopause. Because, let's face it, she's already watching her body change, anxious about aging, being told to fear foods that built her. And she's hitting all of this at the time her estrogen is a bit more erratic.

2:48Dr. Gabrielle Lyon:Maybe her muscle is also walking out the door. Here's the paradox I want to address with you today. The molecular pathway that the longevity world wants you to suppress is the same pathway that builds and protects muscle. We know that muscle is this single and strongest, most modifiable predictor of whether you stay independent or frail. And today I'm going to do something rare. I'm going to give you the strongest version of the protein shortens your life argument to the best of my ability. Then I'm going to walk you through what the evidence shows when you refuse to drop the inconvenient parts.

3:24Dr. Gabrielle Lyon:And by the end, you're going to understand this well enough that nobody on the internet can scare you with words again. You get to decide. Segment one, what mTOR actually is. Let's define the villain. In every story, there's a villain because almost all fear comes from people throwing this word around like a curse word, mTOR. mTOR stands for mechanistic target of rapamycin. It's an enzyme that sits at the center of one of the most important decisions your cells make. Do I grow right now or do I conserve and repair. mTOR switches on when fuel, especially the amino acid leucine, is available, when insulin and growth factors are up, and when your muscle is under load, for example, training.

4:10Dr. Gabrielle Lyon:When it's on, the cells build. It quiets down when you're fasted, calorie restricted, or low on protein. Then the cells shift into a cleanup mode like autophagy, your cellular recycling program. Now, here is the distinction, what I have seen that every viral video gets wrong. mTOR isn't one thing. It runs as two separate complexes. mTOR1 is the build complex. It drives muscle protein synthesis. This is the one that the longevity crowd is afraid of. And then there's mTOR2, which handles glucose and insulin signaling. And here's the catch. Nobody mentions rapamycin, the drug this whole pathway is named after, the drug behind nearly every, quote, mTOR inhibition extends life headline.

4:59It doesn't

5:00Dr. Gabrielle Lyon:cleanly hit only one build complex. And here's the catch no one mentions. Rapamycin, the drug this whole pathway is named after, the drug behind nearly, quote, mTOR inhibition extends life headline, doesn't cleanly hit only the build complex. With chronic use, it suppresses mTOR C2, and that gives you glucose intolerance, insulin resistance, and potentially a weakened immune system. So the next time someone says, just suppress mTOR for longevity, the honest question is the following. Which complex, in which tissue, at which age, and at what dose? Because mTOR isn't a light switch you flip on and off, it's on and in every cell.

5:48Dr. Gabrielle Lyon:There's a dial and that does completely different things in your muscle versus your liver at 30, at 80, after a workout or when you're fasted. Treating it as if it's one villain to be silenced is not sophisticated. It's, do I dare say, biologically illiterate. Now, hold that thought and this is going to carry us through the whole episode. Segment two, the high protein deception and this is the RDA deception, what high protein actually means. Now, before we get into the evidence on either side, we need to fix a definitional problem that has corrupted this entire debate. Because of the words high protein and low protein don't mean what you think they mean, the RDA is not a recommendation.

6:37It is a minimum to prevent deficiency. The RDA is set at 0.8 grams

6:43Dr. Gabrielle Lyon:per kg that was derived from short-term nitrogen balance studies, experiments measuring whether the body is losing more nitrogen than it takes in, which is a marker of net protein loss, albeit not a marker of health, but protein loss. The true physiological minimum, the bare minimum amount needed to maintain nitrogen balance in a healthy young adult male. And that said at, just to round it up, 0.6 grams per kg a day. The RDA adds a safety margin on top of that to cover 97.5 % of the healthy population. It was never designed to define optimal intake for muscle function, disease prevention, or longevity.

7:27It was designed to answer one question, how little protein can a person eat without measurably wasting away? Friends, this is a

7:37Dr. Gabrielle Lyon:very different question from how much protein should a person eat for optimal health? So the RDA sits just above the danger zone. It is a floor, not a target. And here is where the definitional problem poisons the debate. The Levine 2014 study, this is probably one of the most cited papers in the protein shortens lifespan camp, classified high protein as greater than 20 % of the total calories. But the acceptable macronutrient distribution range for protein set by the national academies is the following, 10 to 35 % of total energy. So Levine's quote, high protein falls squarely in the middle of the accepted range.

8:22Dr. Gabrielle Lyon:And at the 2025 dietary guideline changes for Americans, they just moved the recommended protein intake to 1.2 to 1.6 grams per kg, roughly 16 to 21 % of calories, which means what the longevity literature has been calling, quote, dangerously high, is now what the U.S. government calls recommended. The Falgoni 2025 reanalysis of the Levine paper is the closest thing to a direct rebuttal that we've seen. And this study, co-authored by Stu Phillips, one of the most prominent protein researchers in the world and a handful of other experts went back to the exact same data set that Levine used with a larger sample size.

9:05Dr. Gabrielle Lyon:So for example, Levine used around 7 ,000 and this study used around 16 ,000 people and took a longer follow-up and more rigorous intake methodology. What did they find? It found no association between animal protein or plant protein and all-cause mortality in any age group, including the 50 to 65 cohort. IGF-1 showed no link to mortality at any age. Animal protein was mildly protective for cancer mortality. Again, let this land for a moment. The intake that one camp says accelerates aging and causes cancer is the intake that the latest federal dietary guidelines, the Protege Study Group, the European Society for Clinical Nutrition and Metabolism, and the Asian Working Group for Sarcopenia all now recommend, especially for older adults.

10:05The actual protein landscape looks like the following. 0.8 grams per kg a day, this is the RDA, a deficiency prevention floor derived from 1940s era methodology,

10:18Dr. Gabrielle Lyon:essentially unchanged for over 70 years, to now 1.2 to 1.6 grams per kg, the new dietary guidelines, and the range recommended during active weight loss, which is closer to 1.6 grams per kg, which is approximately twice the RDA, the level supported by the Protein Summit 2.0 Consensus for optimal muscle and body composition. Now, the one important exception here as we talk is adults with advanced chronic kidney disease, specifically if your GFR is below 30, who are not on dialysis, you guys need to talk to your doctor. And again, this is a medical decision with your provider. The bottom line for this debate, the next time someone tells you high protein intake is associated with increased mortality, ask them what they mean by high.

11:10Dr. Gabrielle Lyon:Because in most of these studies, high means the intake that every major expert consensus group now recommends. The protein longevity debate has been fought on a battle where the definitions were rigged from the start. What do I mean by these definitions were rigged from the start? Well, what is high protein versus what is low protein. There is a ton of confusion, which is why I laid out those numbers. High protein is not 1.2 to 1.6 grams per kg. That would be a moderate amount of protein simply by definition. Because if the RDA is set at the minimum and you double that, that's moderate. That's not high protein.

11:57Definitions become important because that is

12:00Dr. Gabrielle Lyon:how we are judging the information. Segment three. Now I'm going to argue the case against protein, the other side. And I'm going to argue it to the best of my ability because if I can't state the opposition, then there's no way for me to have earned a right to disagree. Number one, the animal data is genuinely impressive when it comes to mTOR. Rapamycin, the drug that we talked about earlier, is the most reproducible drug we have for extending lifespan in mice. In the gold standard program run across multiple labs specifically to kill off junk findings, it extended medium lifespan somewhere around, this is impressive, 15 to 25%.

12:43Dr. Gabrielle Lyon:That's real. It's been replicated, which is really important. And when you restrict protein or even just the amino acid methionine, which is a model of say a vegan diet, in rodents, you trigger a hormone called FGF21 and you see metabolic benefits and longer life. The coherent biology, less protein, less growth signaling, longer life. Okay, that's number one. Number two, the study everyone quotes. The Levine paper in Cell Metabolism, 2014. And note, Walter Longo is the senior author on this paper. In adults aged 50 to 65, there's that word again, high protein intake was tied to roughly 75 % jump in overall mortality and a several fold jump in cancer death.

13:31And the signal tracked with IGF-1, the major growth hormone you make in response to protein. Number three, the logic is intuitive.

13:41Dr. Gabrielle Lyon:mTOR and IGF-1 promote growth. In an adult, the cells dividing most aggressively are often the ones at risk of turning cancerous. So stop flooring the growth pedal three times a day, lower your cancer risk, slow aging. That's the case. I want you to feel its weight not because it's not nothing. Real scientists believe it. And now we're going to stress test it because honesty cuts both ways. And this is where things kind of start coming apart. Segment four, rodent data is not human data. And unfortunately, I've spent a lot of time with rodents. Here's the thing most people wave off in a single sentence.

14:21Dr. Gabrielle Lyon:Well, mice aren't people. This is really important. Ad libitum-fed laboratory mice are essentially metabolic disease models. And this is critical and it is underappreciated and a confounder in the entire mTOR slash protein restriction longevity literature. The mTOR activation pattern is completely different in this group of, quote, obese mice. This is a key mechanistic point for the podcast. In ad libitum-fed mice, mTORC1 is essentially activated around the clock because the animals never stop eating. A 2024 Cell Report study demonstrated that the observed differences in mTOR activity between the ad libitum and calorie-restricted mice were entirely dependent on when relative to feeding the measurements were taken.

15:15This is not some fundamental biological shift. Mice die of different things than you do. The mouth strains in those landmark longevity studies die mostly of lymphomas and connective tissue tumors.

15:31Dr. Gabrielle Lyon:They don't get atherosclerosis. They don't get Alzheimer's. And here's the part that should stop you because it stop me, a major 2013 analysis found that rapamycin barely touched most actual markers of aging in those mice. The lifespan extension was largely explained by suppressing the specific cancers that kill lab mice. So the precise, honest version of rapamycin extends lifespan is rapamycin can block the tumors that kill a particular mouse. Whether that does anything for the human disease landscape, heart disease, dementia is genuinely unknown. Here's the argument that does hold. Even genetically diverse lab mice still die overwhelmingly of cancer.

16:20Dr. Gabrielle Lyon:And that 2013 analysis found rapamycin lifespan's benefit is largely about suppressing those tumors, not broadly slowing aging. And every one of these mice, diverse or not, lives the same artificial life. Caged, never foraging, fed unlimited chow. And in rodent studies, mTOR is turned on 24 hours a day by constant feeding because that's what rodents do. In humans, last time I checked, there is more of an on-off switch, more of one. You eat, mTOR activates, you stop eating, it quiets down. You cannot model the benefits of dialing down growth in an animal that never stops eating and does nothing all day, and then prescribe it to humans whose actual problem is the opposite.

17:10Not enough muscle, not enough movement, and not enough protein. There is to date, to my knowledge, zero, zero human longevity data. There is no completed human trials showing that suppressing

17:26Dr. Gabrielle Lyon:mTOR extends lifespan or health span or muscle span, the strongest human result is a six-week study showing a better flu vaccine response in older adults. A large trial of an mTOR inhibiting drug in over a thousand older adults designed to reduce respiratory illness failed. So when I say rodent data isn't human data, I'm not waving it off. I'm just telling you to make the leap from a short-lived caged hairy animal raised in a lab that is sedentary to a load-bearing human who needs to be strong at 80 is one of the largest unexamined leaps in all of nutrition science from my perspective. The mTOR longevity story is a beautiful plausible hypothesis.

18:12Dr. Gabrielle Lyon:Anyone selling it to you as a settled fact is running ahead of the evidence. Segment five, the IGF-1 cancer story is smaller than you've been told. This is the heart of it, so stay with me. The whole protein scare leans on one chain. Protein rises IGF-1. IGF-1 causes cancer. Let's look at the chain link by link because it does not hold the weight, no pun intended, they're hanging on to. First, the effect sizes are tiny. Yes, there is a real association between IGF-1 and a few cancers, But size is everything, so I've been told. In the UK biobank, nearly 400 ,000 people, a meaningful rise in IGF-1 nudged cancer risk up by roughly 3 % to 11%, depending on the cancer.

19:02Now, put that in perspective. Smoking raises lung cancer risk by 1 % to 2 ,000%. Obesity, 50 to 100%, we are comparing a speed bump to a cliff and calling them both dangerous driving. Number two, IGF-1 protects against some cancers. In that same data, higher IGF-1 was associated with lower risk of lung, ovarian, and liver cancer, and liver dramatically so. That is not how a real-life cancer fuel behaves.

19:38Dr. Gabrielle Lyon:Real life is messier than the slogan. Third, the age paradox breaks the logic. IGF-1 peaks in puberty and falls your whole adult life. By 70, you're running at maybe half of your young adult levels. But cancer risk climbs as you age, exactly as IGF-1 is dropping. If IGF-1 were really the engine of cancer, those two curves should rise together. They run in opposite directions. Fourth, and this is the one that should change how you feel walking out of here. The relationship with death is U-shaped. When researchers pooled the data, both low and high IGF-1 raised mortality. The safest place was to be in the middle.

20:26And the people with the lowest IGF-1 had a nearly 40 % higher risk of dying than the people in the middle. Think about what that means to you.

20:34Dr. Gabrielle Lyon:If you aggressively crush your IGF-1 by slashing protein, which is exactly the advice the longevity crowd gives, which again, I don't even know if that's going to work. You don't reach some safe zero. You can fall off the other side of the mountain into the low IGF-1 danger zone, which is every bit as deadly. Now the confounders, because this is where the causal chain truly snaps. Calories, not protein, are what most people think they're cutting. And calories barely move IGF-1. The most rigorous human trial cut calories by 25 % for two full years. IGF-1 didn't budge. When researchers pooled the trials, the effect of calorie restriction on IGF-1 was essentially zero.

21:27You only move IGF-1 by starving, cutting intake by half, which no one can live on, at least not for long. Protein does raise IGF-1, but here's the lever everyone's pulling on the wrong end. Total IGF-1 isn't the same as free active IGF-1. Insulin is what frees it up. When you eat carbohydrate, insulin rises, it knocks down the binding protein that keeps IGF-1 leashed and free. Active IGF-1 then goes up, even when total IGF-1 hasn't changed. In a body with insulin resistance, chronic high insulin from too much refined carbohydrates means bioavailable IGF-1 runs high all the time, Not because of protein, because of the insulin.

22:19So picture the advice. Eat less protein to lower your IGF-1 while ignoring the hyperinsulinemia that drives the active fraction. That's grabbing the wrong lever entirely. And when researchers use the one method that's designed to cut through confounding, which is Mendelian randomization, which uses your genes as the natural experiment, the story flips outright. Genetically higher protein intake tracked with lower colorectal cancer risk, while higher carbohydrate intake tracked with higher risk. The German Nutrition Society did a full umbrella review and concluded total protein intake is not associated with breast, prostate, colorectal, ovarian, or pancreatic cancer.

23:09The honest summary. The biggest driver of your IGF-1 is your growth hormone, set by your genes, your age, your sleep, and your body composition. Not by whether you're eating one gram or 1.6 grams of protein per kg. The protein to cancer chain is far weaker than confident voices online would ever admit.

23:33Dr. Gabrielle Lyon:Segment six, what saves you and what harms you? So let's talk about what the strong human data on actual death is. Let's start with the headline that they bury. A massive analysis, 32 studies, over 700 ,000 people found that higher total protein intake was associated with lower death from all causes. Not higher, lower. That's the largest body of human evidence we have. And it points the opposite direction from the scarcity, from scaring people to eat protein. Now the real body count, which I have seen all too much of, sarcopenia. That's age-related loss of muscle and strength, and it roughly doubles your risk of death.